BIOGEN INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
BIOGEN INC. (BIIB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 0 shares for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-06.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2020-02-06
- BIOGEN INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2013-12-31 was 0.00 shares.
- BIOGEN INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2013-09-30 was 0.00 shares.
- BIOGEN INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2013-06-30 was 0.00 shares.
- BIOGEN INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2013-03-31 was 0.00 shares.
- BIOGEN INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2019 was 0.00 shares.
- BIOGEN INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2018 was 0.00 shares.
- BIOGEN INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2017 was 0.00 shares.
- BIOGEN INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2016 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2019-12-31 | 0.00 shares 10-K · filed 2020-02-06 | |||
| 2018-12-31 | 0.00 shares 10-K · filed 2019-02-06 | |||
| 2017-12-31 | 0.00 shares 10-K · filed 2018-02-01 | |||
| 2016-12-31 | 0.00 shares 10-K · filed 2017-02-02 | |||
| 2015-12-31 | 0.00 shares 10-K · filed 2016-02-03 | |||
| 2014-12-31 | 0.00 shares 10-K · filed 2015-02-04 | |||
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | 0.00 shares derived: sum of 2 quarters · filed 2014-02-06 | 0.00 shares derived: sum of 3 quarters · filed 2014-02-06 | 0.00 shares 10-K · filed 2014-02-06 |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | 0.00 shares derived: sum of 2 quarters · filed 2013-10-28 | 0.00 shares 10-Q · filed 2013-10-28 | 0.00 shares derived: sum of 4 quarters · filed 2013-10-28 |
| 2013-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | 0.00 shares 10-Q · filed 2013-07-25 | 0.00 shares derived: sum of 3 quarters · filed 2013-07-25 | 0.00 shares derived: sum of 4 quarters · filed 2013-10-28 |
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-04-25 | 0.00 shares derived: sum of 2 quarters · filed 2013-04-25 | 0.00 shares derived: sum of 3 quarters · filed 2013-10-28 | 0.00 shares derived: sum of 4 quarters · filed 2013-10-28 |
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-05 | 0.00 shares derived: sum of 2 quarters · filed 2013-10-28 | 0.00 shares derived: sum of 3 quarters · filed 2013-10-28 | 0.00 shares 10-K · filed 2013-02-05 |
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | 0.00 shares derived: sum of 2 quarters · filed 2013-10-28 | 0.00 shares 10-Q · filed 2013-10-28 | 0.00 shares derived: sum of 4 quarters · filed 2013-10-28 |
| 2012-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | 0.00 shares 10-Q · filed 2013-07-25 | 0.00 shares derived: sum of 3 quarters · filed 2013-07-25 | 0.00 shares derived: sum of 4 quarters · filed 2013-07-25 |
| 2012-03-31 | 0.00 shares 10-Q · filed 2013-04-25 | 0.00 shares derived: sum of 2 quarters · filed 2013-04-25 | 0.00 shares derived: sum of 3 quarters · filed 2013-04-25 | 0.00 shares derived: sum of 4 quarters · filed 2013-04-25 |
| 2011-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | 0.00 shares derived: sum of 2 quarters · filed 2012-10-25 | 0.00 shares derived: sum of 3 quarters · filed 2012-10-25 | 0.00 shares 10-K · filed 2012-02-03 |
| 2011-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-25 | 0.00 shares derived: sum of 2 quarters · filed 2012-10-25 | 0.00 shares 10-Q · filed 2012-10-25 | 0.00 shares derived: sum of 4 quarters · filed 2012-10-25 |
| 2011-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-24 | 0.00 shares 10-Q · filed 2012-07-24 | 0.00 shares derived: sum of 3 quarters · filed 2012-07-24 | 0.00 shares derived: sum of 4 quarters · filed 2012-07-24 |
| 2011-03-31 | 0.00 shares 10-Q · filed 2012-05-01 | 0.00 shares derived: sum of 2 quarters · filed 2012-05-01 | 0.00 shares derived: sum of 3 quarters · filed 2012-05-01 | 4.00K shares derived: sum of 4 quarters · filed 2012-05-01 |
| 2010-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-04 | 0.00 shares derived: sum of 2 quarters · filed 2011-10-28 | 4.00K shares derived: sum of 3 quarters · filed 2011-10-28 | 124.00K shares 10-K · filed 2011-02-04 |
| 2010-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | 4.00K shares derived: sum of 2 quarters · filed 2011-10-28 | 124.00K shares 10-Q · filed 2011-10-28 | |
| 2010-06-30 | 4.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-26 | 124.00K shares 10-Q · filed 2011-07-26 | ||
| 2010-03-31 | 120.00K shares 10-Q · filed 2011-04-21 | |||
| 2009-12-31 | 1.03M shares 10-K · filed 2011-02-04 | |||
| 2008-12-31 | 1.48M shares 10-K · filed 2011-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |